Lumexa Imaging Holdings, Inc. (LMRI) Stock Analysis
Healthcare · Medical Devices
Hold if already holding. Not a fresh buy at $6.58, but acceptable to hold if already in. Reason: Market cap $0.67B below $1B minimum.
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well... Read more
Hold if already holding. Not a fresh buy at $6.58, but acceptable to hold if already in. Reason: Market cap $0.67B below $1B minimum. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Market cap $0.67B below $1B minimum. Not in investable universe. Score 4.8/10, moderate confidence.
Passes 8/9 gates (positive momentum, favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 85d clear, semi cycle peak clear, materials cycle peak clear). Suitability: aggressive.
Recent Developments — Lumexa Imaging Holdings, Inc.
Latest news
- Barclays Maintains Overweight on Lumexa Imaging Hldgs, Lowers Price Target to $9 — benzinga May 20, 2026
- 12 Health Care Stocks Moving In Wednesday's Intraday Session — benzinga May 13, 2026
- Lumexa Imaging Holdings Q1 2026 Earnings Call Transcript — benzinga May 12, 2026
- Lumexa Imaging Holdings Sees FY2026 Adj EPS $0.71-$0.77 vs $0.73 Est; Narrows FY2026 Sales Guidance from $1.045B-$1.097B — benzinga May 12, 2026
- Lumexa Imaging Holdings Q1 Adj. EPS $0.18 Beats $0.12 Estimate, Sales $252.500M Beat $251.004M Estimate — benzinga May 12, 2026
Generated 2026-05-20T20:21:21Z.
Thesis
Key Metrics
Quality Signals
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
4 floor-breakers
Unprofitable operations — net margin -3.7%. Quality floor flags this regardless of sector context.static
No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $6.58, but acceptable to hold if already in. Reason: Market cap $0.67B below $1B minimum. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Market cap $0.67B below $1B minimum. Not in investable universe. Target $16.41 (+149.4%), stop $6.51 (−1.1%), A.R:R 9.0:1. Score 4.8/10, moderate confidence.
Take-profit target: $16.41 (+134.4% upside). Target $16.41 (+149.4%), stop $6.51 (−1.1%), A.R:R 9.0:1. Stop-loss: $6.51.
Market cap $0.67B below $1B minimum.
Lumexa Imaging Holdings, Inc. trades at a P/E of N/A (forward 7.3). TrendMatrix value score: 7.9/10. Verdict: Hold.
14 analysts cover LMRI with a consensus score of 4.4/5. Average price target: $19.
What does Lumexa Imaging Holdings, Inc. do?Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides...
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina.